Latest Payments News

Bank of Queensland Limited announces a fully franked quarterly distribution of AUD 1.337 per Capital Note 3 security, payable in November 2025. The payment reflects a total annualised rate of 5.19%, based on the 3-month BBSW plus margin, adjusted for franking credits.

360 Capital REIT has reported a significant turnaround with a $1.3 million statutory profit for FY25, alongside reduced distributions and a new long-term investment management agreement. The fund’s portfolio remains stable, supported by improved leasing and ESG upgrades.

Lendlease Group has announced a fully franked ordinary dividend of AUD 0.1696 per security for the first half of FY25, alongside a Dividend Reinvestment Plan with no discount.

Amaero Ltd reported a 470% revenue surge to $3.8 million for FY2025, driven by expanded production capacity and exclusive supply deals, while continuing to invest heavily in infrastructure and operations, resulting in a $24.4 million loss.

PointsBet Holdings has updated shareholders on MIXI Australia’s unconditional takeover offer, raising the cash price to $1.25 per share and securing unanimous board support. The company also dismissed a rival scrip bid from Betr Entertainment as inferior.

Audinate Group Limited reported a 32% revenue decline and a net loss in FY25 amid industry headwinds, while expanding gross margins and completing a strategic acquisition to boost its video capabilities.

AML3D Limited reported a modest increase in revenue for FY2025 but saw its losses widen significantly, raising questions about its path to profitability.

REA Group has appointed Cameron McIntyre as its new CEO, succeeding Owen Wilson who will retire from full-time executive duties. McIntyre’s proven leadership in digital marketplaces positions him to steer REA’s expansion and innovation.

Silex Systems Limited has announced a Share Purchase Plan (SPP) aiming to raise up to $15 million, offering existing eligible shareholders new shares at a price capped at $3.90 or a 2% discount to recent trading prices. This follows a $130 million institutional placement and supports key commercialisation projects in uranium enrichment.

Lumos Diagnostics has submitted its CLIA waiver application for FebriDx® to the FDA, backed by strong clinical data and triggering significant milestone payments. Approval could expand the U.S. market opportunity fifteen-fold to over $1 billion.

Aurizon Holdings Limited has announced a fully franked ordinary dividend of AUD 0.065 per share for the six months ending June 2025, payable in September.

Ampol Limited has announced a fully franked ordinary dividend of AUD 0.40 per share for the six months ending June 2025, signaling steady returns for shareholders.